Abstract: Disclosed is a Cas12 protein, a guide polynucleotide, an inactivated Cas12 mutant, a fusion protein or conjugate including the Cas12 protein, an isolated nucleic acid, a CRISPR-Cas12 system, a vector system, a delivery system, a cell, a pharmaceutical composition, and a kit, and uses thereof.

Abstract: Cas12 protein, guide polynucleotide, inactivated Cas12 mutant, fusion protein or conjugate including the Cas 12 protein, isolated nucleic acid, CRISPR-Cas12 system, vector system, delivery system, cell, pharmaceutical composition, and kit, and the use thereof are provided.

Abstract: Provided is a method for detecting a target nucleic acid in a sample, comprising the following steps: reacting the sample with a mixed reaction system consisting of a sgRNA-Cas system and a recombinase-aid isothermal amplification system; and detecting a detectable signal generated by the reaction after the reaction is completed. The sgRNA-Cas system comprises a Cas12b protein and a sgRNA targeting the target nucleic acid; the recombinase-aid isothermal amplification system comprises a primer, a single-stranded DNA reporter molecule that generates the detectable signal after being cleaved. When a reagent user operates, a sample adding and mixing operation of stopping the reaction midway to add reaction component of the second step is leaved out, so that uniformity and coherence of the operation are better, facilitating the improvement of reaction precision. The operation of opening a reaction tube after the amplification reaction of recombinant polymerase is omitted.